Reimbursement conditions for avatrombopag in domestic medical insurance

Avatrombopag (Avatrombopag) is a medicine used to treat certain types of thrombocytopenia. It belongs to the thrombopoietin receptor agonist (TPO-Ragonist) class of drugs. Platelets are a cellular component of blood that are responsible for the process of hemostasis and clotting. When patients have thrombocytopenia, the number of platelets in their blood is lower than normal, which can lead to bleeding problems.

Reimbursement conditions for avatrombopag under domestic medical insurance Only adult patients with chronic liver disease-related thrombocytopenia who undergo elective diagnostic procedures or surgeries. Avatrombopag has now been officially launched in China and has been included in the national medical insurance system, making it easy for patients to purchase this drug in China. Its selling price is roughly in the range of 3,000 to 4,000 yuan, but the specific price and medical insurance reimbursement ratio may vary due to regional differences. It is recommended that patients directly consult the pharmacy of the local hospital to obtain the most accurate information. It is worth mentioning that the price of foreign generic drugs of avatrombopag is relatively more affordable. In particular, the price of generic drugs on the market in places such as Laos and Bangladesh is only a few hundred to one thousand yuan. It is understood that these generic drugs are basically the same as the original drugs in terms of drug ingredients, thus providing patients with more affordable options.

Avatrombopag helps prevent or reduce the risk of bleeding events by promoting platelet production in the bone marrow to increase platelet numbers. It is often used to treat chronic immune thrombocytopenia (ITP), a disorder in which the immune system attacks its own platelets, resulting in low platelets.

Avatrombopag is typically used when other treatments are ineffective or inappropriate, such as in patients who have failed to respond to oral steroids. It may be used as a long-term treatment option or as a short-term treatment to boost a patient's platelet levels before surgery.

However, like all medications, avatrombopag may cause side effects, including headache, nausea, fatigue, and more. Therefore, before using avatrombopag, doctors typically evaluate a patient's overall health and potential risks and discuss treatment expectations and possible side effects with the patient in detail. Patients should use the medication as directed by their doctor and have regular follow-up visits to monitor efficacy and any adverse reactions.